Jean Philippe Galanaud, Jean Pierre Laroch, and Marc Righini on Historical Treatments of DVT
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”The history and historical treatments of deep vein thrombosis: toward the era of new anticoagulants
By Jean Philippe Galanaud, Jean Pierre Laroch, and Marc Righini
• Context: Over centuries, the management of deep vein thrombosis (DVT) has evolved from empirical bloodletting to the precision of direct oral anticoagulants (DOACs).
• Overview: This historical review traces how DOACs revolutionized therapy—simplifying treatment, redefining duration and intensity, and reshaping clinical guidelines.
• Reflection: Despite progress, the “philosopher’s stone” of anticoagulation—perfect safety without loss of efficacy—remains elusive. Novel FXI/XIa inhibitors and AI-guided individualized therapy may herald the next transformation in DVT care.”
Read the full article in JTH.
Article: The history and historical treatments of deep vein thrombosis: toward the era of new anticoagulants
Authors: Jean Philippe Galanaud, Jean Pierre Laroch, Marc Righini
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 2, 2026, 10:31Fayad Al-Haimus: Is Giving TXA Within “3 Hours” Really Enough?
-
Feb 2, 2026, 10:07David Benito Laorga’s Haemophilia Team Hosts Hemosfera
-
Feb 2, 2026, 09:49Tichakunda Mharazanye: A New Year, New Challenges, And New Milestones
-
Feb 2, 2026, 09:16Eyiuche Ezigbo Calls for Stronger VWD Awareness and Better Care in LMICs
-
Feb 2, 2026, 09:04Nicolas de Prost։ Plasma Exchange in Severe ANCA-Associated Vasculitis With DAH
-
Feb 2, 2026, 08:56Bartosz Hudzik on Cancer With ACS: Big Step Forward for Cardio-Oncology
-
Feb 2, 2026, 08:35Karine Kocharian on Armenia-Led WHA Resolution on Hemophilia at WHO Executive Board
-
Feb 2, 2026, 07:12The 2026 Application Cycle for ASH’s International Outreach Initiative is Now Open – ASH
-
Feb 1, 2026, 13:32Shiny K. Kajal: A Series On Reaching the Diagnosis of Immune Thrombocytopenia